Shelly Simana's research lies at the intersection of bioethics and law, addressing ethical and legal challenges that arise as a consequence of scientific advancements in genetics, reproductive technologies, and biotechnology. Central to her research are two intertwined questions: what impact do advances in genetics, reproduction, and biotechnology have on individuals and society; and, how does the law shape this impact? These advances hold the potential to revolutionize health and well-being—but only if the law is set on a path that allows them to do so.
Simana's work has been published inÌýUC Irvine Law Review,ÌýYale Journal of Law & Technology,ÌýJournal of Law, Medicine & Ethics,ÌýJournal of Law and the Biosciences,ÌýJournal of Medical Ethics, Bioethics, andÌýCurrent Stem Cell Reports, and has been cited by the New York State Supreme Court.
Prior to joining 51²è¹Ý Law, Simana was a postdoctoral fellow at the Center for Law and the Biosciences at Stanford Law School, as well as a doctoral candidate at Harvard Law School. While pursuing her doctoral degree, Simana served as a teaching fellow at Harvard Law School, Harvard Medical School, and the Harvard T.H. Chan School of Public Health. She was also a research associate in the Program on Science, Technology, and Society (STS) at the Harvard Kennedy School of Government. Prior to her doctoral studies, Shelly was a visiting scholar in the Department of Bioethics at the National Institutes of Health (NIH), a clerk in Israel's High Court of Justice Department at the State Attorney’s Office, and an associate attorney at S. Horowitz & Co., focusing on health law regulation.
